156 related articles for article (PubMed ID: 10874456)
1. Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
Böhme A; Karthaus M; Hoelzer D
Antibiot Chemother (1971); 2000; 50():69-78. PubMed ID: 10874456
[No Abstract] [Full Text] [Related]
2. [Efficacy of itraconazole injections for treatment of febrile neutropenia].
Saito T; Inoue Y; Kato A; Takimoto M; Suzuki T; Iyoshi N; Arai T; Shibuya Y; Suzuki Y; Kato M; Takahashi M; Miura I; Ogawa K
Jpn J Antibiot; 2008 Apr; 61(2):95-8. PubMed ID: 18709730
[No Abstract] [Full Text] [Related]
3. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
5. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution.
Lass-Flörl C; Gunsilius E; Gastl G; Englisch M; Koch G; Ulmer H; Dierich MP; Petzer A
Ann Hematol; 2003 Sep; 82(9):565-9. PubMed ID: 14504812
[TBL] [Abstract][Full Text] [Related]
6. Delay of onset of candidemia and emergence of Candida krusei fungemia in hematologic patients receiving prophylactic fluconazole.
Jarque I; Saavedra S; Martin G; Pemán J; Pérez Bellés C; Sanz MA
Haematologica; 2000 Apr; 85(4):441-3. PubMed ID: 10757896
[No Abstract] [Full Text] [Related]
7. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
8. European experience with oral solution and intravenous itraconazole.
Potter M
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):27-32. PubMed ID: 11757848
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
Böhme A; Karthaus M; Hoelzer D
Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
[TBL] [Abstract][Full Text] [Related]
10. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
12. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
Wirk B; Wingard JR
Mycopathologia; 2009 Dec; 168(6):299-311. PubMed ID: 19247798
[TBL] [Abstract][Full Text] [Related]
13. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
15. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
16. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
Gubbins PO; Bowman JL; Penzak SR
Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
[TBL] [Abstract][Full Text] [Related]
17. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
Böhme A; Karthaus M
Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
[TBL] [Abstract][Full Text] [Related]
18. [Prophylactic use of oral itraconazole solution for febrile neutropenia associated with hematologic malignancies].
Nakagawa Y; Suzuki N
Jpn J Antibiot; 2008 Apr; 61(2):102-4. PubMed ID: 18709732
[No Abstract] [Full Text] [Related]
19. [Impact of antifungal prophylaxis on the gastrointestinal yeast colonisation in patients with haematological malignancies].
Rimek D; Redetzke K; Kappe R
Mycoses; 2006; 49 Suppl 2():18-23. PubMed ID: 17022757
[TBL] [Abstract][Full Text] [Related]
20. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
